Abeona Therapeutics faces a pivotal FDA decision after a CRL-led crash and partial rebound in pz-cel’s valuation. Check out ...

Abeona Therapeutics Inc.’s ABEO share price has surged by 6.34%, which has investors questioning if this is right time to ...

Avicanna reported annual revenue of CA$25.5 million ($18.38 million) for the year ended December 31, 2024, up 52% compared to ...

Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for ...

LEO Pharma and the Parker Institute at Copenhagen University Hospital have entered into a three-year academic partnership aimed at advancing dermatology research. The alliance will focus on enhancing ...

Hannah Campbell announced the tragic news of her infant's death on April 8 with a TikTok post shared to over 769,000 ...

which is developing the first and only protein replacement therapy currently being investigated for the treatment of dystrophic epidermolysis bullosa (DEB). The second, was Premacure AB ...

DEB is one of the more severe forms of the epidermolysis bullosa (EB) group – sometimes ... Before now, the only treatment was palliative care. Vyjuvek – which has been approved for both ...

Faced with an ongoing struggle for his son's survival and relief from pain, Frank Luis Vento García, the father of a ...

Annual Revenue: Achieved record revenue of $25.5 million for the year ended December 31, 2024, supported by $6.6 million in ...